Dr. Sanzgiri is a registered patent attorney with experience in the general areas of life-sciences, pharmaceuticals and biotechnology.
Dr. Sanzgiri's practice includes all aspects of domestic and foreign patent preparation and prosecution, reexamination proceedings, patentability and freedom to operate opinions, due diligence reviews and patent litigation support. Dr. Sanzgiri has expertise in the fields of genetics, biochemistry, immunology, neuroscience, cancer biology, and drug development. Her clients range from early stage biotech start-ups to established publicly funded companies, as well as non-profit research institutes and universities.
Prior to her legal career, Dr. Sanzgiri had an active research career. She worked as a research associate in the biochemistry division of Bhabha Atomic Research Center (BARC), in Mumbai, India. Later, Dr. Sanzgiri obtained her Ph.D. in genetics from Iowa State University, where she studied cellular signaling in the mammalian nervous system in the laboratory of Dr. Phil Haydon. Dr. Sanzgiri further conducted post-doctoral research in neuroscience with Dr. Irwin Levitan and Dr. Leslie Griffith at Brandeis University.
University of Colorado School of Law (J.D. Dean's List, 2006)
Iowa State University (Ph.D., Genetics, 1998)
University of Pune, India (M.S., Biotechnology, 1990)
University of Mumbai, India (B.S., Chemistry, 1988)
United States Patent and Trademark Office, 2006
American Bar Association
Colorado Bar Association - Director of IP Section of Colorado Bar
South Asian Bar Association
Rockies Venture Club
Colorado Bio-Sciences Association
Colorado Super Lawyers, Rising Star, 2016
Excellence-in-Research award, Iowa State University
Production Editor, Journal on Telecommunications High Technology Law
Dean’s List, University of Colorado
Speaker: “Obviousness-Type Double Patenting” American Intellectual Property Law Association, July 2017.
Speaker, Moderator: "BioBreakfast: A Look at the Judicial Impact on Biotech Innovation," Colorado BioScience Association, March 3, 2016.
Patenting on a Budget, Thought Leader at Rockies Venture Club Academy, 2013 and 2014
Prostaglandin-E2 stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured hippocampal cells, Journal of Neurobiology, 1999.
Astrocyte-induced modulation of synaptic transmission, Canadian Journal of Physiology and Pharmacology, 1999.
Tripartite synapses: Glia, the unacknowledged partner, Trends in Neuroscience, 1999.
Calcium elevation in astrocytes causes an NMDA receptor-dependent increase in the frequency of miniature synaptic currents in cultured hippocampal neurons, Journal of Neuroscience, 1998.
Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons, European Journal of Neuroscience, 1998.
Prostaglandin-E2 stimulates an astrocyte-evoked NMDA and non- NMDA glutamate receptor dependent slow inward current in neurons, Society for Neuroscience Abstracts, 1998.
Calcium elevation in astrocytes causes an NMDA receptor-dependent increase in the frequency of the miniature synaptic currents in cultured hippocampal neurons, Society for Neuroscience Abstracts, 1998.
Calcium elevation in astrocytes is sufficient to cause an NMDA receptor-dependent increase in the frequency of the miniature synaptic currents in cultured hippocampal neurons, Society for Neuroscience Abstracts, 1998.
Synaptotagmin I enhances transferrin uptake in primary cultured astrocytes, Society for Neuroscience Abstracts, 1997.
Overexpression of synaptic proteins in primary cultured astrocytes, Society for Neuroscience Abstracts, 1996.
Modular structural elements in the replication origin region of Tetrahymena rDNA, Nucleic Acids Research, 1995.
Site directed mutagenesis of DNA polymerase I (Klenow) from Escherichia coli : The significance of arginine 682 in catalysis, European Journal of Biochemistry, 1993.
Cloning and overproduction of the large proteolytic fragment (Klenow) of Escherichia coli DNA polymerase I, Current Science, 1992.